Fcpm Iii Services B.v.

Latest statistics and disclosures from Fcpm Iii Services B.v.'s latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Fcpm Iii Services B.v. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Fcpm Iii Services B.v.

Fcpm Iii Services B.v. holds 6 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Newamsterdam Pharma Company Ordinary Shares (NAMS) 39.0 $132M 12M 11.17
 View chart
Dyne Therapeutics (DYN) 24.0 $82M 6.1M 13.30
 View chart
Engene Holdings (ENGN) 23.6 $80M 8.7M 9.23
 View chart
Replimune Group (REPL) 12.1 $41M 4.9M 8.43
 View chart
Engene Holdings W Exp 10/31/2028 (ENGNW) 0.7 $2.3M 3.9M 0.60
 View chart
Achilles Therapeutics Sponsored Ads (ACHL) 0.6 $2.1M 2.4M 0.89
 View chart

Past Filings by Fcpm Iii Services B.v.

SEC 13F filings are viewable for Fcpm Iii Services B.v. going back to 2023